<div>Ch 1: Present and future of urinary stents.- Ch 2: Indications, Complications and side effects of Ureteral stents.- Ch 3: Indications, Complications and side effects of metallic ureteral stents.- Ch 4: Urethral stents. Indications, complications and adverse effects.- Ch 5: Ureteral stents. Impact on patient’s quality of life..- Ch 6: Strategies to improve the quality of life of stented patients.- Ch 7: Use of drugs to reduce the morbidity of ureteral stents.- Ch 8: Ureteral stent designs to reduce stent-related symptoms and improve patient quality of life.- Ch 9: Encrustation in urinary stents.- Ch 10: Forgotten ureteral stent syndrome.- Ch 11: Endourological management of encrusted ureteral stents.- Ch 12: Pediatric Ureteral Stents.- Ch 13: Flow dynamics in stented ureter.- Ch 14: Methodology for the development and validation of new stent designs: in vitro and in vivo models.- Ch 15: Methodology on clinical evaluation of urinary stents.- Ch 16: A Dynamically Degradable Surface: Can We ‘Fool’ Bacteria to Delay Biofouling in Urinary Stents?.- Ch 17: Biomaterials for ureteral stents: advances and future perspectives.- Ch 18: Coatings for urinary stents:current state and future directions.- Ch 19: Bacterial adhesion and biofilm formation: hydrodynamics effects.- Ch 20: Biomaterial-associated infection: pathogenesis and prevention.- Ch 21: Antibiotic-free solutions for the development of biofilm prevention coatings.- Ch 22: Plasma Based Approaches for Deposition And Grafting Of Antimicrobial Agents To Polymer Surfaces.- Ch 23: Antimicrobial biosurfactants towards the inhibition of biofilm formation.- Ch 24: Novel antimicrobial strategies to combat biomaterial infections.- Ch 25: Light-activated polymer nanocomposites doped with a new type of carbon quantum dots for antibacterial applications.- Ch 26: Nanoparticles. Potential for use to prevent infections.- Ch 27: Urinary tract infections and encrustation in urinary stents.- Ch 28: Learning from our mistakes:Applying Vascular Stent Technologies to the Urinary Tract.- Ch 29: Biodegradable urinary stents.- Ch 30: New double-J stent design for preventing/reducing irritative bladder symptoms & flank pain.- Ch 31: Drug eluting devices in the urinary tract.- Ch 32: Methods and Materials for drug eluting urinary stents design and fabrication.- Ch 33: Preventing biofilm formation and encrustation on urinary implants: (bio)coatings and tissue engineering.- Ch 34: Preventing biofilm formation and encrustation on urinary implants: (bio)molecular and physical research approaches.- Ch 35: Ten steps to strategic planning for the urinary stents of the future.</div><p></p>
